Mark J. Ratain to Receptors, Endothelin
This is a "connection" page, showing publications Mark J. Ratain has written about Receptors, Endothelin.
Connection Strength
0.015
-
Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies. Clin Cancer Res. 2004 Jul 01; 10(13):4406-11.
Score: 0.015